The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1017438
WO Application Number:
SE1998000457
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP98909946.0
WO Publication Number:
WO1998041256
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:
Dates
Filing date:
13/03/1998
Grant date:
15/09/2004
EP Publication Date:
15/09/2004
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/04/2017
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/09/2004
EP B1 Publication Date:
15/09/2004
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/03/2018
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
15/09/2004
Name:
AstraZeneca AB
Address:
Gobal Intellectual Property, S-151 85, Södertälje, Sweden (SE)
Domicile Holder
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/09/2004
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)